Cryo-Save Group N.V. - EGM resolutions: new Board composition paves the way to a profitable future
(Thomson Reuters ONE) -
Cryo-Save Group N.V. (Euronext: CRYO, 'Cryo-Save', or 'the Group'), the leading
international stem cell storage company and the largest family stem cell bank in
Europe, announces that all proposed resolutions at today's EGM were passed.
Cryo-Save, and the Group's largest shareholder, Mr. Frédéric Amar together with
Salveo Holding S.A. have now resolved all their disputes.
Mr. Walter Van Pottelberge and Mr. Ronald Lorijn remain non-executive directors
of the Board of Cryo-Save and Mr. Van Pottelberge has been reconfirmed as the
Chairman of the Board. Ms Karin Dorrepaal's resignation has been accepted and
the Group is grateful for her contribution during her tenure.
Cryo-Save's Board of Directors has been strengthened by the appointment of 2 new
non-executive directors.
Mr. Frédéric Amar with a degree in Crystallography (1990) and a degree in
Pharmacy (Pharm.D.) from the Université de Pharmacie of Marseilles (1992) joins
the board with a strong scientific background and a successful track record in
building up and managing companies. He also founded Salveo Biotechnology S.A., a
Geneva based private laboratory specialized in stem cells cryopreservation and
cell culture and involved in cellular therapeutic applications research, with a
commercial presence in Italy, Spain, Switzerland, Romania and Ukraine.
Mr. Gert-Jan van der Marel earned his Masters degree in Business Economics
(1974) from the University of Groningen, The Netherlands and obtained his MBA
from INSEAD, Fontainebleau, France (1978). Mr. Van der Marel brings valuable and
highly relevant expertise in turnaround management and more than 30 years
experience in international management.
Cryo-Save's new Board will support the management to continue the implementation
of the "Fit for Future" turnaround strategy, which is well on track and will
ensure that the Company will swing back to profitability by year-end, leading to
a sustainable profitable future and a healthy upside from the next wave of
growth of stem cell therapy.
Enquiries:
Cryo-Save Group + 31 (0) 575 548 998
Walter van Pottelberge, Chairman
Click here for full press release in PDF:
http://hugin.info/143308/R/1744972/587228.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Cryo-Save Group N.V. via Thomson Reuters ONE
[HUG#1744972]
Unternehmensinformation / Kurzprofil:
Datum: 21.11.2013 - 16:28 Uhr
Sprache: Deutsch
News-ID 319317
Anzahl Zeichen: 3067
contact information:
Town:
Zutphen
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 153 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Cryo-Save Group N.V. - EGM resolutions: new Board composition paves the way to a profitable future"
steht unter der journalistisch-redaktionellen Verantwortung von
Cryo-Save Group N.V. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
